Want to see MMED full AI Analyst Report?

MiniMed Group, Inc. (MMED) Stock Forecast & Price Target

64 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

MMED Analyst Ratings

Strong Buy

11 Buy

0 Hold

0 Sell

Based on 11 analysts giving stock ratings to

MiniMed

Group, Inc.

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

MMED Stock 12 Month Forecast

Average Price Target

$26.40

▲(31.34% Upside)

Based on 11 Wall Street analysts offering 12 month price targets for MiniMed Group, Inc. in the last 3 months. The average price target is $26.40 with a high forecast of $29.00 and a low forecast of $21.00. The average price target represents a 31.34% change from the last price of $20.10.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"11":"$11","30":"$30","15.75":"$15.75","20.5":"$20.5","25.25":"$25.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":29,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$29.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":26.4,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$26.40</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":21,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$21.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[11,15.75,20.5,25.25,30],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2026","6":"Apr<br/>2026","9":"Jul<br/>2026","12":"Oct<br/>2026","25":"Oct<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,19.47,20.20307692307692,20.936153846153847,21.66923076923077,22.40230769230769,23.135384615384616,23.86846153846154,24.60153846153846,25.334615384615383,26.067692307692308,26.80076923076923,27.533846153846156,28.266923076923078,{"y":29,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,19.47,20.00307692307692,20.536153846153844,21.069230769230767,21.60230769230769,22.135384615384613,22.668461538461536,23.201538461538462,23.73461538461538,24.267692307692307,24.800769230769227,25.333846153846153,25.866923076923076,{"y":26.4,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,19.47,19.587692307692308,19.705384615384613,19.823076923076922,19.94076923076923,20.058461538461536,20.176153846153845,20.293846153846154,20.411538461538463,20.529230769230768,20.646923076923077,20.764615384615386,20.88230769230769,{"y":21,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":18.49,"date":1759276800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":18.49,"date":1761955200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":18.49,"date":1764547200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":18.49,"date":1767225600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":18.49,"date":1769904000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":18.49,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.48,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.11,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15.19,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.05,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":22.42,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":19.47,"date":1790812800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$29.00

Average Price Target$26.40

Lowest Price Target$21.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Richard Newitter

Truist Financial

$29

Buy

44.28%

Upside

Initiated

09/24/26

MiniMed initiated with a Buy at TruistMiniMed initiated with a Buy at Truist

Kallum Titchmarsh

Morgan Stanley

$21

Buy

4.48%

Upside

Assigned

09/18/26

Morgan Stanley Sticks to Its Buy Rating for MiniMed Group, Inc. (MMED)

Steven Lichtman

William Blair

―

Buy

―

Reiterated

09/14/26

Analyst Initiates Buy on MiniMed, Citing Attractive Valuation and Favorable Medtronic Share-Exchange Structure

Larry Biegelsen

Wells Fargo

$22→$26

Buy

29.35%

Upside

Reiterated

09/08/26

Wells Fargo Sticks to Their Buy Rating for MiniMed Group, Inc. (MMED)

Daniel Markowitz CFA

Evercore ISI

$20→$27

Buy

34.33%

Upside

Reiterated

09/02/26

MiniMed price target raised to $27 from $20 at Evercore ISIMiniMed price target raised to $27 from $20 at Evercore ISI

Anthony Petrone

Mizuho Securities

$21→$26

Buy

29.35%

Upside

Reiterated

09/02/26

MiniMed price target raised to $26 from $21 at MizuhoMiniMed price target raised to $26 from $21 at Mizuho

Pito Chickering

Deutsche Bank

$20→$25

Buy

24.38%

Upside

Assigned

09/02/26

MiniMed price target raised to $25 from $20 at Deutsche BankMiniMed price target raised to $25 from $20 at Deutsche Bank

Joanne Wuensch

Citi

$23→$26

Buy

29.35%

Upside

Reiterated

09/02/26

MiniMed price target raised to $26 from $23 at CitiMiniMed price target raised to $26 from $23 at Citi

Patrick Wood

UBS

$25→$28

Buy

39.30%

Upside

Reiterated

09/02/26

MiniMed price target raised to $28 from $25 at UBSMiniMed price target raised to $28 from $25 at UBS

Travis Steed

Bank of America Securities

$24→$28

Buy

39.30%

Upside

Reiterated

09/01/26

Analyst Travis Steed Reiterates Buy on MiniMed, Boosts Price Target from $24 to $28 on Strong Growth Outlook and Pipeline Acceleration

Marie Thibault

BTIG

$25→$28

Buy

39.30%

Upside

Reiterated

09/01/26

Analysts Are Bullish on These NA Stocks: MiniMed Group, Inc. (MMED), Upstream Bio, Inc. (UPB)

Matthew O'Brien

Piper Sandler

$16

Hold

-20.40%

Downside

Reiterated

06/04/26

Piper Sandler Reaffirms Their Hold Rating on MiniMed Group, Inc. (MMED)

David Roman

Goldman Sachs

$14.01→$24

Buy

19.40%

Upside

Reiterated

06/03/26

David Roman Lifts MiniMed Price Target to $24, Citing Strong Growth, Margin Outperformance and Compelling Valuation

Bruce Jackson

Benchmark Co.

$20

Buy

-0.50%

Downside

Reiterated

06/03/26

Benchmark Co. Reaffirms Their Buy Rating on MiniMed Group, Inc. (MMED)

Matt Miksic

Barclays

$26

Buy

29.35%

Upside

Initiated

03/31/26

MiniMed initiated with an Overweight at BarclaysMiniMed initiated with an Overweight at Barclays

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Richard Newitter

Truist Financial

$29

Buy

44.28%

Upside

Initiated

09/24/26

MiniMed initiated with a Buy at TruistMiniMed initiated with a Buy at Truist

Kallum Titchmarsh

Morgan Stanley

$21

Buy

4.48%

Upside

Assigned

09/18/26

Morgan Stanley Sticks to Its Buy Rating for MiniMed Group, Inc. (MMED)

Steven Lichtman

William Blair

―

Buy

―

Reiterated

09/14/26

Analyst Initiates Buy on MiniMed, Citing Attractive Valuation and Favorable Medtronic Share-Exchange Structure

Larry Biegelsen

Wells Fargo

$22→$26

Buy

29.35%

Upside

Reiterated

09/08/26

Wells Fargo Sticks to Their Buy Rating for MiniMed Group, Inc. (MMED)

Daniel Markowitz CFA

Evercore ISI

$20→$27

Buy

34.33%

Upside

Reiterated

09/02/26

MiniMed price target raised to $27 from $20 at Evercore ISIMiniMed price target raised to $27 from $20 at Evercore ISI

Anthony Petrone

Mizuho Securities

$21→$26

Buy

29.35%

Upside

Reiterated

09/02/26

MiniMed price target raised to $26 from $21 at MizuhoMiniMed price target raised to $26 from $21 at Mizuho

Pito Chickering

Deutsche Bank

$20→$25

Buy

24.38%

Upside

Assigned

09/02/26

MiniMed price target raised to $25 from $20 at Deutsche BankMiniMed price target raised to $25 from $20 at Deutsche Bank

Joanne Wuensch

Citi

$23→$26

Buy

29.35%

Upside

Reiterated

09/02/26

MiniMed price target raised to $26 from $23 at CitiMiniMed price target raised to $26 from $23 at Citi

Patrick Wood

UBS

$25→$28

Buy

39.30%

Upside

Reiterated

09/02/26

MiniMed price target raised to $28 from $25 at UBSMiniMed price target raised to $28 from $25 at UBS

Travis Steed

Bank of America Securities

$24→$28

Buy

39.30%

Upside

Reiterated

09/01/26

Analyst Travis Steed Reiterates Buy on MiniMed, Boosts Price Target from $24 to $28 on Strong Growth Outlook and Pipeline Acceleration

Marie Thibault

BTIG

$25→$28

Buy

39.30%

Upside

Reiterated

09/01/26

Analysts Are Bullish on These NA Stocks: MiniMed Group, Inc. (MMED), Upstream Bio, Inc. (UPB)

Matthew O'Brien

Piper Sandler

$16

Hold

-20.40%

Downside

Reiterated

06/04/26

Piper Sandler Reaffirms Their Hold Rating on MiniMed Group, Inc. (MMED)

David Roman

Goldman Sachs

$14.01→$24

Buy

19.40%

Upside

Reiterated

06/03/26

David Roman Lifts MiniMed Price Target to $24, Citing Strong Growth, Margin Outperformance and Compelling Valuation

Bruce Jackson

Benchmark Co.

$20

Buy

-0.50%

Downside

Reiterated

06/03/26

Benchmark Co. Reaffirms Their Buy Rating on MiniMed Group, Inc. (MMED)

Matt Miksic

Barclays

$26

Buy

29.35%

Upside

Initiated

03/31/26

MiniMed initiated with an Overweight at BarclaysMiniMed initiated with an Overweight at Barclays

Stocks with the Highest Top Analyst Consensus in the General Sector

STDNStandard Nuclear

SKHYSK Hynix

ITGITG Inc. Class A

LIMENeutron Holdings, Inc.

EROCERock

Find stocks in the General sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering MiniMed Group, Inc.

3 Months

Travis SteedBank of America Securities

Success Rate

5/6 ratings generated profit

Average Return

+27.62%

Copying Travis Steed's trades and holding each position for 3 Months would result in 83.33% of your transactions generating a profit, with an average return of +27.62% per trade.

1 Year

Travis SteedBank of America Securities

Success Rate

5/6 ratings generated profit

Average Return

+30.48%

Copying Travis Steed's trades and holding each position for 1 Year would result in 83.33% of your transactions generating a profit, with an average return of +30.48% per trade.

2 Years

Travis SteedBank of America Securities

Success Rate

5/6 ratings generated profit

Average Return

+30.48%

Copying Travis Steed's trades and holding each position for 2 Years would result in 83.33% of your transactions generating a profit, with an average return of +30.48% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

MMED Analyst Recommendation Trends

Rating

Jun 26

Jul 26

Aug 26

Sep 26

Oct 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, MMED has received 16 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. MMED average Analyst price target in the past 3 months is 26.40.

Each month's total comprises the sum of three months' worth of ratings.

MMED Financial Forecast

MMED Earnings Forecast

The previous quarter’s earnings for MMED were $0.00.

MMED Sales Forecast

The previous quarter’s earnings for MMED were $843.00M.

MMED Stock Forecast FAQ

What is MMED’s average 12-month price target, according to analysts?

Based on analyst ratings, MiniMed Group, Inc.’s 12-month average price target is 26.40.

What is MMED’s upside potential, based on the analysts’ average price target?

MiniMed Group, Inc. has 31.34% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is MMED a Buy, Sell or Hold?

MiniMed Group, Inc. has a consensus rating of Strong Buy which is based on 11 buy ratings, 0 hold ratings and 0 sell ratings.

What is MiniMed Group, Inc.’s price target?

The average price target for MiniMed Group, Inc. is 26.40. This is based on 11 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $29.00 ,the lowest forecast is $21.00. The average price target represents 31.34% Increase from the current price of $20.1.

What do analysts say about MiniMed Group, Inc.?

MiniMed Group, Inc.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 11 Wall Streets Analysts.

How can I buy shares of MMED?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

MiniMed Group, Inc. (MMED) Stock Forecast & Price Target

MMED Analyst Ratings

MMED Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering MiniMed Group, Inc.

MMED Analyst Recommendation Trends

MMED Financial Forecast

MMED Earnings Forecast

MMED Sales Forecast

MMED Stock Forecast FAQ

Detailed List of Analyst Forecasts